Here we show a critical function of the inhibitory ITIM-receptor FcγRIIb in CML stem cell persistence and therapeutic targeting of malignant FcγRIIb-mediated signaling enhanced TKI-mediated cell death in CML stem cells. Here, FCGR2B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.